Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility
MicroRNAs are small, noncoding molecules of about twenty-two nucleotides with crucial
roles in both healthy and pathological cells. Their expression depends not only on genetic …
roles in both healthy and pathological cells. Their expression depends not only on genetic …
[HTML][HTML] First-line immunotherapy for advanced non-small cell lung cancer: current progress and future prospects
J Wang, L Wu - Cancer Biology & Medicine, 2023 - pmc.ncbi.nlm.nih.gov
Global Cancer Statistics 2022 reported the prevalence and high mortality rate of lung
cancer. Notably, non-small cell lung cancer (NSCLC) accounts for the majority of the …
cancer. Notably, non-small cell lung cancer (NSCLC) accounts for the majority of the …
Preparation of Biomimetic Selenium–Baicalein Nanoparticles and Their Targeted Therapeutic Application in Nonsmall Cell Lung Cancer
H Shi, B Wang, H Ma, Y Li, J Du, B Zhang… - Molecular …, 2024 - ACS Publications
In this study, we prepared bionic selenium–baicalein nanoparticles (ACM-SSe–BE) for the
targeted treatment of nonsmall cell lung cancer. Due to the coating of the A549 membrane …
targeted treatment of nonsmall cell lung cancer. Due to the coating of the A549 membrane …
The Triterpenoid CDDO-Methyl Ester Reduces Tumor Burden, Reprograms the Immune Microenvironment, and Protects from Chemotherapy-Induced Toxicity in a …
JA Moerland, KT Liby - Antioxidants, 2024 - mdpi.com
NRF2 activation protects epithelial cells from malignancy, but cancer cells can upregulate
the pathway to promote survival. NRF2 activators including CDDO-Methyl ester (CDDO-Me) …
the pathway to promote survival. NRF2 activators including CDDO-Methyl ester (CDDO-Me) …
Unraveling Th subsets: insights into their role in immune checkpoint inhibitor therapy
M Ryba-Stanisławowska - Cellular Oncology, 2024 - Springer
T helper (Th) cell subsets play pivotal roles in regulating immune responses within the tumor
microenvironment, influencing both tumor progression and anti-tumor immunity. Among …
microenvironment, influencing both tumor progression and anti-tumor immunity. Among …
[HTML][HTML] Heterogeneity of lymphocyte subsets in predicting immune checkpoint inhibitor treatment response in advanced lung cancer: an analysis across different …
C Miao, Y Chen, H Zhang, W Zhao… - Translational Lung …, 2024 - pmc.ncbi.nlm.nih.gov
Background Immune checkpoint inhibitor (ICI) has become pivotal in the treatment of
advanced lung cancer, yet the absence of reliable biomarkers for assessing treatment …
advanced lung cancer, yet the absence of reliable biomarkers for assessing treatment …
Establishment of a prognostic signature for hepatocellular carcinoma using disulfidptosis-related lncRNAs
Y Yang, C Zhou, X Ma, N Xu, D Ding, Z Ma, H Liu… - 2023 - researchsquare.com
Background Disulfidptosis is a recently discovered form of programmed cell death that may
be a new direction in tumor treatment. Long non-coding RNAs (lncRNAs) play an important …
be a new direction in tumor treatment. Long non-coding RNAs (lncRNAs) play an important …